Akari Therapeutics (AKTX) Return on Assets (2015 - 2026)

Akari Therapeutics (AKTX) has 11 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Assets fell to 0.01% in Q1 2026 per AKTX's latest filing, from 0.0% in the prior quarter.
• The five-year high for Return on Assets was 0.0% in Q2 2025, with the low at 0.05% in Q3 2024.
• Average Return on Assets over 4 years is 0.02%, with a median of 0.01% recorded in 2022.
• Year-over-year, Return on Assets changed 0 bps in 2022 and increased 5 bps in 2025.
• Akari Therapeutics' Return on Assets stood at 0.01% in 2022, then tumbled by 35 bps to 0.01% in 2024, then soared by 47 bps to 0.0% in 2025, then plunged by 80 bps to 0.01% in 2026.
• Business Quant data shows AKTX's Return on Assets at 0.01% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.